ORTEXORTEX News
Tracking KMI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
KM
Trader NoteKMI

KMI Trails Peers on Price but Leads on Analyst Conviction

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 19:49

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Kinder Morgan gained 0.8% over the past week, a solid week in isolation but one that lagged the midstream peer group, where WMB rose 5.3%, DTM added 4.9%, and OKE gained 3.4%. KMI's short interest, at roughly 2% of the free float, is the lightest in that peer set. The lending market backs that up: availability is running at more than 7,000%, meaning there are vastly more shares available to borrow than are currently borrowed. This is not a stock attracting speculative pressure.

The more interesting story this week is on the Street. A wave of analysts lifted price targets following last week's Q3 earnings beat, and the moves have continued into this week. Morgan Stanley raised its target to $40 from $38, keeping Equal-Weight. RBC Capital lifted to $38 from $36, also maintaining its neutral stance. That follows Jefferies, Wells Fargo, TD Cowen, Mizuho, and BMO Capital all moving targets higher on October 22. The direction of travel across the group is unanimous: every firm that moved in the past week raised, none cut. The consensus mean target now stands at $37.27 against a stock price of $33.85, implying around 10% upside. The rating mix remains split evenly between buys and holds, and the neutral-rated firms are raising targets rather than flipping positive, which reflects genuine earnings delivery but some hesitation on valuation at these levels. The EV/EBITDA sits at 11.9x, down slightly over the past month but up roughly 2x on the P/E over 30 days, reflecting the stock's 10% price gain over that period.

The bull case rests on a sharply expanded project backlog, which rose by $4.7 billion to $9.6 billion, with LNG export demand, data centre gas supply, and the Southeast Connector and Permian Link projects underpinning long-dated take-or-pay contract revenue. FY26 EBITDA guidance was raised to $9.1 billion. Bears point to fossil-fuel exposure and the sensitivity of commodity-linked earnings to weaker gas and crude prices, plus re-contracting risk. Factor scores tilt toward the income and stability side: the dividend score ranks in the 97th percentile, and the analyst recommendation differential sits at 92nd percentile, both reflecting the sustained buy-side interest in KMI as an infrastructure income name. EPS momentum scores are more muted, in the mid-40s on both 30-day and 90-day measures, suggesting the earnings revision cycle is constructive but not accelerating.

Wikipedia traffic for KMI is running at a z-score of 2.6 against its own 90-day history, the highest retail attention reading in that window. That spike coincides with the earnings release and the subsequent analyst activity. The alt data carries no measured leading indicators for KMI's reported figures, so this is colour on interest rather than a signal on fundamentals. Insider activity over the past 90 days is negligible in economic terms: one VP has sold 1,550 shares per month under a 10b5-1 plan, a mechanical, pre-scheduled programme rather than a discretionary view. Net insider value over 90 days is minus $150,000, a rounding error for a $75 billion company.

Richard Kinder retains an 11.6% personal stake, an anchor position that has been unchanged since at least March. BlackRock added 1.9 million shares in the most recent quarter, State Street added 5.4 million, and JP Morgan Asset Management added 3 million. Goldman Sachs Asset Management added 4.6 million, bringing its total to 18.9 million shares. The institutional flow picture is incrementally positive across multiple large passive and active managers.

ORTEX puts the probability of a share-count increase in the CRSP US Mid index at the December 2026 Quarterly Review at 52%, with an estimated $639 million of buying by index trackers if confirmed. The rank date is December 4, announcement December 7, and the effective date December 23. Separately, ORTEX puts the probability of KMI leaving the CRSP US Mega index at 52%, with the price that decides it set at $34.05. The stock closed at $33.85, putting it 0.6% below that exit line. With the next earnings report not due until January 20, 2027, the December index review and whether the stock can hold above $34.05 into the rank date are the near-term mechanical catalysts worth tracking.

Stocks in this article

See the live data behind this article on ORTEX.

Open KMI on ORTEX →

How this article was generated

Generated
28 Oct 2026, 19:53
Data as of
28 Oct 2026, 19:49
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.